Benslama, Noura
Bollard, Julien
Vercherat, Cécile
Massoma, Patrick
Roche, Colette
Hervieu, Valérie
Peron, Julien
Lombard-Bohas, Catherine
Scoazec, Jean-Yves
Walter, Thomas
Funding for this research was provided by:
LYric grant (INCa-DGOS 4664)
Article History
Received: 19 April 2016
Accepted: 18 May 2016
First Online: 26 May 2016
Compliance with ethical standards
:
: T Walter, JY Scoazec have acted as advisory board member for Ipsen, Pfizer and Novartis.All other authors: no conflict of interest.
: This study received financial support from Novartis and la Ligue Contre le Cancer du Rhône, France.C Vercherat is recipient of a post-doctoral grant from LYric grant INCa-DGOS 4664.